DGRO is recommended as the better choice for the remainder of 2026 due to its meaningful growth exposure and tech sector tilt (20%), which aligns with expected earnings growth and market leadership. Despite lower year-to-date returns (8.4%), it is positioned to benefit from continued tech and growth stock outperformance.
Articles that tag DGRO but are mainly about other companies.
The article highlights DGRO's strong 10-year annualized returns of 13.5%, recent year-to-date gains of 11%, competitive dividend yield of 1.95%, low expense ratio of 0.08%, and diversified sector allocation that reduces exposure to potential AI bubble risks. It is recommended as a buy-and-hold investment for 20 years.
The ETF is presented as an ideal investment vehicle for volatile market conditions, with a track record of double-digit returns over 1-, 3-, 5-, and 10-year periods combined with lower volatility (beta of 0.67). It holds 390 quality companies screened for dividend growth sustainability, making it a recommended solution for portfolio stability.
Presented as a superior alternative with significantly lower expense ratio (0.08% vs 0.45%), much larger asset base ($43.15 billion), and lower risk profile, making it more attractive for cost-conscious investors.
Presented as a superior alternative with significantly lower expense ratio (0.08% vs DGRS's 0.38%) and substantially larger asset base ($42.89 billion), making it more attractive for cost-conscious investors.
Presented as a superior alternative with significantly lower expense ratio (0.08% vs 0.58%) and substantially larger assets ($43.83 billion), making it a more cost-effective choice.
Presented as a viable alternative with significantly lower expense ratio (0.08%) and substantially larger asset base ($43.51 billion), making it a more cost-efficient option for dividend growth investors.
Presented as an alternative option with significantly lower expense ratio (0.08%) and much larger asset base ($43.58 billion), but lacks specific performance data in the article.
Recommended for focus on dividend growth potential with 390 quality large-cap holdings across diversified sectors, reasonable 0.08% expense ratio, and emphasis on financial stability.
Recommended for its strong combination of dividend growth and quality, with sustainable payout ratios and earnings growth criteria that create a high-quality portfolio suitable for long-term investors.
Considered a solid option but flagged for poor sector balance with 21% in financials and 18% in healthcare during periods of potential secular headwinds in both industries, limiting its suitability for long-term stability.
Recommended as a 'no-brainer' investment with strong outperformance in 2026, well-diversified portfolio, low expense ratio (0.08%), and well-positioned to handle macro risks through balanced sector allocation and consistent dividend payments.
Recommended as a balanced alternative combining features of the other two ETFs, with unique dividend-dollar-weighted construction and a 3% holding cap that provides a different performance profile and diversification benefits.
Presented as an alternative dividend-focused ETF option for investors looking to invest in dividend payers with consistent growth, supporting the article's thesis on dividend growth strategies.
Highlighted for strong 11%+ annualized returns over multiple periods, dividend growth focus with 2% yield, nearly 400 quality holdings, and rock-bottom 0.08% expense ratio.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology